001     638309
005     20251119161754.0
024 7 _ |a 10.1107/S2053230X25005266
|2 doi
024 7 _ |a 1744-3091
|2 ISSN
024 7 _ |a 2053-230X
|2 ISSN
024 7 _ |a 10.3204/PUBDB-2025-04027
|2 datacite_doi
024 7 _ |a openalex:W4412172097
|2 openalex
037 _ _ |a PUBDB-2025-04027
041 _ _ |a English
082 _ _ |a 530
100 1 _ |a Kloskowski, Patrick
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Nucleotide-bound crystal structures of the SARS-CoV-2 helicase NSP13
260 _ _ |a Oxford [u.a.]
|c 2025
|b Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1762773773_3263425
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Funding for this research was provided by the DeutscheForschungsgemeinschaft (Germany’s Excellence StrategyEXC 2067/1-390729940 to RF and grant No. INST186/1117 toRF).
520 _ _ |a Nucleotide-bound crystal structures of SARS-CoV-2 NSP13 in ADP- and ATP-bound states were resolved to 1.8 and 1.9 Å, respectively. The ADP-bound model captures a state immediately following ATP hydrolysis, with both ADP and orthophosphate still present in the active site. Further comparative analysis revealed that crystal packing influences NSP13 by stabilizing the nucleotide-binding site, underscoring the importance of accounting for these effects in structure-based drug design targeting NSP13.
536 _ _ |a 6G3 - PETRA III (DESY) (POF4-6G3)
|0 G:(DE-HGF)POF4-6G3
|c POF4-6G3
|f POF IV
|x 0
536 _ _ |a DFG project G:(GEPRIS)390729940 - EXC 2067: Multiscale Bioimaging: Von molekularen Maschinen zu Netzwerken erregbarer Zellen (390729940)
|0 G:(GEPRIS)390729940
|c 390729940
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |a PETRA III
|f PETRA Beamline P13
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P13-20150101
|6 EXP:(DE-H253)P-P13-20150101
|x 0
700 1 _ |a Neumann, Piotr
|b 1
700 1 _ |a Berndt, Annette
|b 2
700 1 _ |a Ficner, Ralf
|0 P:(DE-H253)PIP1018222
|b 3
|e Corresponding author
773 _ _ |a 10.1107/S2053230X25005266
|g Vol. 81, no. 8, p. 338 - 347
|0 PERI:(DE-600)2175956-X
|n 8
|p 338 - 347
|t Acta crystallographica / Section F
|v 81
|y 2025
|x 1744-3091
856 4 _ |u https://journals.iucr.org/f/issues/2025/08/00/no5212/index.html
856 4 _ |u https://bib-pubdb1.desy.de/record/638309/files/Nucleotide-bound%20crystal%20structures%20of%20the%20SARS-CoV-2%20helicase%20NSP13.pdf
|y OpenAccess
856 4 _ |u https://bib-pubdb1.desy.de/record/638309/files/Nucleotide-bound%20crystal%20structures%20of%20the%20SARS-CoV-2%20helicase%20NSP13.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:bib-pubdb1.desy.de:638309
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 3
|6 P:(DE-H253)PIP1018222
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-H253)PIP1018222
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Großgeräte: Materie
|1 G:(DE-HGF)POF4-6G0
|0 G:(DE-HGF)POF4-6G3
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v PETRA III (DESY)
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-20
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA CRYSTALLOGR F : 2022
|d 2024-12-20
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-20
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-20
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
920 1 _ |0 I:(DE-H253)EMBL-User-20120814
|k EMBL-User
|l EMBL-User
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)EMBL-User-20120814
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21